...
首页> 外文期刊>Cells tissues organs >Epidermal growth factor-, transforming growth factor-beta-, retinoic acid- and 1,25-dihydroxyvitamin D3-regulated expression of the novel protein PTPIP51 in keratinocytes.
【24h】

Epidermal growth factor-, transforming growth factor-beta-, retinoic acid- and 1,25-dihydroxyvitamin D3-regulated expression of the novel protein PTPIP51 in keratinocytes.

机译:表皮生长因子-,转化生长因子-β-,维甲酸和1,25-二羟基维生素D3调节角质形成细胞中新型蛋白质PTPIP51的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

The novel protein PTPIP51 (protein tyrosine phosphatase-interacting protein 51), which has been found to interact with protein tyrosine phosphatases of the PTP1B/TcPTP subfamily, is expressed in all suprabasal layers of human epidermis. Hence, a human keratinocyte cell line (HaCaT) grown on culture slides was used as a simplified model system to study the influence of hormonal agents on the regulation of PTPIP51 expression. Results were obtained by immunocytochemistry and subsequent statistical analysis. Additionally, immunoblotting was performed to detect the possible occurrence of distinct molecular weight forms as described previously. Subcellular localization of PTPIP51 protein was analyzed by specific staining of cellular organelles. HaCaT cells were subjected to treatment with factors that are crucial for the regulation of proliferation and differentiation of keratinocytes in human epidermis: epidermal growth factor (EGF), transforming growth factor-beta(TGF-beta), retinoic acid (RA) and 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)]. Epidermal growth factor receptor (EGFR) expressed in HaCaT cells was inhibited by PD153035. Only about 35% of untreated HaCaT cells were immunoreactive for the PTPIP51 protein. Whereas cells treated with increasing concentrations of 1,25 (OH)(2)D(3) showed a stepwise numerical increase of PTPIP51-positive cells, treatment with RA did not influence the number of PTPIP51-positive cells except when supraphysiological concentrations were applied. Concentration-dependent increase of cells stained positive for PTPIP51 was also observed when HaCaT cells were subjected to EGF treatment. Additional treatment of these cells with PD153035 led to a slight decrease in the fraction of PTPIP51-positive cells, which was not statistically significant. Immunoblotting results suggest a specific pattern of different molecular weight forms of PTPIP51 being expressed in HaCaT cells. Subcellular analysis revealed an association of the protein with mitochondria in nonconfluent cells, whereas confluent cells lack such correlation. The intracellular distribution of PTPIP51 resembled the localization of its interacting partner TcPTP. Furthermore, PTPIP51 was found to be present in both the nucleus and cytoplasm of HaCaT cells. In summary, the results indicate a possible association of PTPIP51 expression with differentiation as well as with apoptosis of keratinocytes.
机译:在人表皮的所有基底上层表达了新型蛋白质PTPIP51(与酪氨酸磷酸酶相互作用的蛋白质51),该蛋白质与PTP1B / TcPTP亚家族的蛋白质酪氨酸磷酸酶相互作用。因此,在培养玻片上生长的人角质形成细胞系(HaCaT)被用作简化的模型系统来研究激素对PTPIP51表达调节的影响。通过免疫细胞化学和随后的统计分析获得结果。另外,如先前所述,进行了免疫印迹以检测不同分子量形式的可能发生。通过细胞器的特异性染色分析了PTPIP51蛋白的亚细胞定位。对HaCaT细胞进行了处理,这些因素对于调节人表皮中角质形成细胞的增殖和分化至关重要:表皮生长因子(EGF),转化生长因子β(TGF-beta),视黄酸(RA)和1 25-二羟基维生素D(3)[1,25(OH)(2)D(3)]。在HaCaT细胞中表达的表皮生长因子受体(EGFR)被PD153035抑制。未经处理的HaCaT细胞中只有约35%对PTPIP51蛋白具有免疫反应性。尽管浓度升高的1,25(OH)(2)D(3)处理的细胞显示PTPIP51阳性细胞的数值逐步增加,但是用RA处理不会影响PTPIP51阳性细胞的数量,除非应用超生理学浓度。 。 HaCaT细胞经过EGF处理后,还观察到了PTPIP51染色阳性的细胞的浓度依赖性增加。用PD153035进一步处理这些细胞会导致PTPIP51阳性细胞的分数略有下降,这在统计学上并不显着。免疫印迹结果表明在HaCaT细胞中表达了不同分子量形式的PTPIP51的特定模式。亚细胞分析揭示了非融合细胞中蛋白质与线粒体的相关性,而融合细胞则缺乏这种相关性。 PTPIP51的细胞内分布类似于其相互作用的伙伴TcPTP的本地化。此外,发现PTPIP51存在于HaCaT细胞的细胞核和细胞质中。总之,结果表明PTPIP51表达与分化以及角质形成细胞的凋亡可能相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号